Dec 28, 1989 - Clarification on OSHA's Hazard Communication Standard.Dec 28, 1989 - Clarification on OSHA's Hazard Communication Standard.
The Home page of ILPI's Safety Data Sheet (SDS) Resource, the leader in SDS information since 1995!
The history and philosophy behind this resource.
A curated collection of books and reference materials concerning Safety Data Sheets and closely related topics.
Paste your plain text SDS into the SDS-Demystifier, and it will be converted into a hypertext-enriched document with links to detailed explanations of each key term.
An extensive list of frequently asked questions about Safety Data Sheets including regulations, content, compliance, and more.
A humorous take on Safety Data Sheet jargon. Fill in the blanks on our entry form to generate a personalized Unsafety Data Sheet to share with your coworkers.
Since 1995, we've maintained this massive curated list of the best places to find Safety Data Sheets on the Internet.
Way more than a glossary, this hypertext-enhanced resource covers hundreds of SDS-related terms and expert knowledge. Each entry includes both the SDS relevance and links to additional authoritative resources.
Archived results of Safety Data Sheet related polls taken by some of our millions of site visitors
You are here! The OSHA regulations behind SDS regulations, including the inspection guidelines and over 400 official interpretations letters under the Hazard Communication Standard
Commercial suppliers of SDS authoring and management software as well as cloud compliance services.
Commercial companies that will create SDS's for your specific needs as well as SDS translation companies.
Safety signs, banners, and scoreboards? Get yours at Safety Emporium!
OSHA Hazard Communication Letters of Interpretation
Clarification on OSHA's Hazard Communication Standard.
ILPI assessment: SDS principle retained; drug exemption and paragraph numbers updated
This letter addresses the obsolete 1987 version of the Hazard Communication Standard (HCS). Its main HazCom conclusion remains useful: a package insert or drug reference is not automatically a substitute for a required SDS. The proposed 1988 change was not an operative exemption at the time, and the letter is not a complete current drug-exemption statement.
Under the current HCS, apply the full drug exemption and separate FDA labeling exemption. The latter requires that the product actually be subject to the specified FDA labeling requirements; it is not a categorical exemption for every filled IV bag or syringe. For nonexempt hazardous drugs, use current SDS content. The letter's (b)(6)(viii) reference is not the present drug paragraph; historical numbering is preserved and explained below.
Hazard communication standard and pharmaceuticals() Coverage depends on hazards and applicable exemptions, and occasional crushing of a pill not normally dispensed that way differs from a drug designed for crushing or dissolving.
This comparison with current requirements is not a finding that OSHA has formally withdrawn this letter. This assessment reflects editorial judgment informed by human review and AI assistance. It is an opinion, may contain errors or omissions, and is not an official OSHA determination. For guidance on how OSHA requirements apply to your circumstances, contact your local OSHA office.
OSHA's notice about interpretation letters
The following notice is published on OSHA's interpretation pages; it is general guidance, not a letter-specific withdrawal notice.
OSHA requirements are set by statute, standards and regulations. Our interpretation letters explain these requirements and how they apply to particular circumstances, but they cannot create additional employer obligations. This letter constitutes OSHA's interpretation of the requirements discussed. Note that our enforcement guidance may be affected by changes to OSHA rules. Also, from time to time we update our guidance in response to new information. To keep apprised of such developments, you can consult OSHA's website at https://www.osha.gov.
Your first item of concern was whether or not FDA-approved pharmaceutical drugs are covered by the HCS [ILPI:Original HCS 1987 context (PDF) · Current HCS]. As you correctly pointed out in your letter, section (b)(6)(viii) [ILPI:Original HCS 1987 context (PDF) · Current HCS; now 1910.1200(b)(6)(vii)] exempts from coverage under the standard drugs that are in solid, final form, ready for direct administration, to the patient such as tablets, or pills. This exemption is based on the Agency's determination that the potential for employee exposure to any hazardouschemicals is minimal for drugs that are in final solid form or are pre-packaged for sale to consumers.
[ILPI note: At issuance: 1910.1200, 1987 expanded rule (PDF). Current drug exemption: (b)(6)(vii), with additional specified retail-packaged/personal-use cases. The letter's cited number is historical; it must not lead to the current cosmetics exemption.]
You next questioned whether material safety data sheets (MSDS) are required for "end users" of pharmaceutical drugs, and whether the package inserts that accompany drugs along with information in the Physicians Desk Reference can be used in lieu of the date sheets. In response to this question and other issues you raised, I am enclosing a copy of OSHA's August, 1988 Proposed Rule as reprinted from the Federal Register. While OSHA has proposed this change to the standard (see page 29852. section (c), "Definition" for "Material Safety Data Sheets"), at the present time MSDS are required for all hazardouschemicals, including pharmaceuticals, where there is the potential for employee exposure. Package inserts, etc. cannot be utilized in lieu of the MSDS since they do not meet the specification requirements of MSDS under the present rule.
In response to your last question, pharmaceutical drugs that are subject to labeling requirements administered by the Food and Drug Administration (FDA) under the Federal Food, Drug and Cosmetic Act are exempt from the labeling provisions of OSHA's HCS (see the HCS at section (b) (5) (ii) [ILPI:Original HCS 1987 context (PDF) · Current HCS]), since they are required to meet FDA's specific labeling requirements. IV bags and syringes containing various drugs are not, therefore, required to be labeled per the requirements of the HCS.
I hope this information is useful to you in addressing the concerns you raised. Please do not hesitate to contact us again if you have any further questions.
Sincerely,
Thomas J. Shepich, Director Directorate of Compliance Program